Adam H. Schechter
Net Worth
Last updated:
What is Adam H. Schechter net worth?
The estimated net worth of Mr. Adam H. Schechter is at least $79,191,315 as of 11 Nov 2024. He owns shares worth $24,114,479 as insider, has earned $1,506,836 from insider trading and has received compensation worth at least $53,570,000 in Laboratory Corporation of America Holdings.
What is the salary of Adam H. Schechter?
Mr. Adam H. Schechter salary is $4,870,000 per year as Pres, Chief Executive Officer & Chairman in Laboratory Corporation of America Holdings.
How old is Adam H. Schechter?
Mr. Adam H. Schechter is 60 years old, born in 1965.
What stocks does Adam H. Schechter currently own?
As insider, Mr. Adam H. Schechter owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Laboratory Corporation of America Holdings (LH) | Pres, Chief Executive Officer & Chairman | 87,441 | $275.78 | $24,114,479 |
What does Laboratory Corporation of America Holdings do?
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.
Adam H. Schechter insider trading
Laboratory Corporation of America Holdings
Mr. Adam H. Schechter has made 2 insider trades between 2014-2024, according to the Form 4 filled with the SEC. Most recently he sold 6,189 units of LH stock worth $1,506,836 on 11 Nov 2024.
The largest trade he's ever made was exercising 72,435 units of LH stock on 27 Mar 2024. As of 11 Nov 2024 he still owns at least 87,441 units of LH stock.